Martin A. Lee is the co-founder and director of Project CBD and the author of several books, including Smoke Signals: A Social History of Marijuana–Medical, Recreational and Scientific, which received the American Botanical Council’s James A. Duke Award for Excellence in Botanical Literature. Named by High Times as one of the 100 most influential people in cannabis, he is the 2016 winner of the Emerald Cup’s Lifetime Achievement Award. Lee is also co-founder of the media watch group FAIR (Fairness & Accuracy In Reporting) and the author of Acid Dreams: The Complete Social History of LSD–The CIA, the Sixties and Beyond.
Martin A. Lee
Although it may not be obvious during these Trump-rattled times, we’re in the midst of a psychedelic revival. There is more interest than ever before in experimenting with LSD, magic mushrooms, ayahuasca, ketamine, and other psychedelic drugs.
During the first week of July 2018, five-hundred-and-thirty-five delegates from five continents met at the University of Leiden in the Netherlands for the 28th annual symposium of the International Cannabinoid Research Society (ICRS). The four-day conference showcased recent scientific discoveries about
Graft-versus-host disease (GVHD) is a common – and potentially fatal – complication following bone marrow and solid organ transplants. This life threatening condition can also occur after a patient receives a blood transfusion or other forms of transplanted tissue from a genetically different person.
Traumatic brain injury (TBI) is one of the leading causes of death worldwide in individuals under the age of 45. Triggered by concussions from car accidents, falls, violent contact sports, explosives or by gunshot and stab wounds, TBI affects 1.7 million Americans annually. It is the most commonly identified cause of epilepsy among adults.